Shared genetic basis for migraine and ischemic stroke

Neurology

Volumn 84, Issue 21, 2015, Pages 2132-2145

  Malik, Rainer ^a   Freilinger, Tobias ^a,b   Winsvold, Bendik S ^c,d   Anttila, Verneri ^d,g,h,i   Vander Heiden, Jason ^j   Traylor, Matthew ^k   De Vries, Boukje ^l   Holliday, Elizabeth G ⁿ   Terwindt, Gisela M ^m   Sturm, Jonathan ^o,q   Bis, Joshua C ^r   Hopewell, Jemma C ^t   Ferrari, Michel D ^m   Rannikmae, Kristiina ^w   Wessman, Maija ^x,y   Kallela, Mikko ^aa   Kubisch, Christian ^ab,ac   Fornage, Myriam ^ad   Meschia, James F ^ae   Lehtimäki, Terho ^af   Sudlow, Cathie ^w   Clarke, Robert ^t   Chasman, Daniel I ^i,ag   Mitchell, Braxton D ^ah   Maguire, Jane ^n,p   Kaprio, Jaakko ^y,z,ai   Farrall, Martin ^q,u   Raitakari, Olli T ^aj   Kurth, Tobias ^{i,ah,ak,al,am}   Ikram, M Arfan ^an,ao,ap,aq   Reiner, Alex P ^y,ar   Longstreth, W T ^s   Rothwell, Peter M ^v   Strachan, David P ^as   Sharma, Pankaj ^at   Seshadri, Sudha ^au   Quaye, Lydia ^av   Cherkas, Lynn ^av   Schürks, Markus ^ah,aw   Rosand, Jonathan ^e,g,i   Ligthart, Lannie ^ax   Boncoraglio, Giorgio B ^ay   Davey Smith, George ^az   Van Duijn, Cornelia M ^an,aq   Stefansson, Kari ^ba   Worrall, Bradford B ^bb   Nyholt, Dale R ^bc   Markus, Hugh S ^k   Van Den Maagdenberg, Arn M J M ^l,m   Cotsapas, Chris ^bd   Zwart, John A ^c   Palotie, Aarno ^d,e,f,h,be   Dichgans, Martin ^a,bf   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Analytical and Translational Genetics Unit Department of Medicine   (Norway)

^e Psychiatric and Neurodevelopmental Genetics Unit   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g Program in Medical and Population Genetics   (United States)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j YALE UNIVERSITY   (United States)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^l Departments of Human Genetics   (United Kingdom)

^m LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY OF NEWCASTLE   (Australia)

^o School of Health Sciences   (Australia)

^p School of Nursing and Midwifery   (United States)

^q University of Newcastle ^*  (Japan)

^r Cardiovascular Health Research Unit   (United States)

^s UNIVERSITY OF WASHINGTON   (United States)

^t CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^u UNIVERSITY OF OXFORD   (United Kingdom)

^v UNIVERSITY OF OXFORD   (United Kingdom)

^w UNIVERSITY OF EDINBURGH   (United Kingdom)

^x FOLKHÄLSAN RESEARCH CENTER   (Finland)

^y Institute for Molecular Medicine Finland (FIMM)   (Finland)

^z UNIVERSITY OF HELSINKI   (Finland)

^aa HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ab UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^ac UNIVERSITY OF ULM   (Germany)

^ad UNIVERSITY OF TEXAS   (United States)

^ae MAYO CLINIC   (United States)

^af TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^ag BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ah UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^ai NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^aj Department of Clinical Physiology and Nuclear Medicine and Research Centre of Applied and Preventive Cardiovascular Medicine   (United States)

^ak TURKU UNIVERSITY HOSPITAL   (Finland)

^al INSERM   (France)

^am UNIVERSITÉ DE BORDEAUX   (France)

^an Departments of Microbiology and Epidemiology   (United States)

^ao Departments of Neurology   (United States)

^ap ERASMUS MEDICAL CENTER   (Netherlands)

^aq Netherlands Centre for Healthy Aging   (Netherlands)

^ar Fred Hutchinson Cancer Research Center   (United States)

^as ST GEORGE S HOSPITAL   (United Kingdom)

^at IMPERIAL COLLEGE LONDON   (United Kingdom)

^au BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^av KING'S COLLEGE LONDON   (United Kingdom)

^aw UNIVERSITY HOSPITAL ESSEN   (Germany)

^ax Department of Biological Psychology   (Netherlands)

^ay NATIONAL CANCER INSTITUTE   (Italy)

^az UNIVERSITY OF BRISTOL   (United Kingdom)

^ba DECODE GENETICS   (Iceland)

^bb UNIVERSITY OF VIRGINIA   (United States)

^bc QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^bd YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^be WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^bf Germany 3 Munich Cluster for Systems Neurology   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ISCHEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC LOAD; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SIGNAL PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; STROKE;

BRAIN ISCHEMIA; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; STROKE;

EID: 84929932178     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001606     Document Type: Article

References (38)

1. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999;53:537-542.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-1757.
3. Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012;11:92-100.
4. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
5. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914.
6. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010; 123:612-624.
7. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010;67:221-229.
8. Stam AH, Haan J, van den Maagdenberg AM, Ferrari MD, Terwindt GM. Migraine and genetic and acquired vasculopathies. Cephalalgia 2009;29:1006-1017.
9. Zeller JA, Frahm K, Baron R, Stingele R, Deuschl G. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry 2004;75:984-987.
10. Friberg L, Olesen J, Lassen NA, Olsen TS, Karle A. Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke 1994;25:974-979.
11. Anttila V, Winsvold BS, Gormley P, et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 2013;45:912-917.
12. Freilinger T, Anttila V, de Vries B, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 2012;44:777-782.
13. Anttila V, Stefansson H, Kallela M, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 2010;42: 869-873.
14. Gschwendtner A, Bevan S, Cole JW, et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 2009;65:531-539.
15. Traylor M, Farrall M, Holliday EG, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genomewide association studies. Lancet Neurol 2012;11:951-962.
16. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353-357.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24: 35-41. International Hap Map Consortium
18. Frazer KA, Ballinger DG et al. A second generation human haplotype map of over 3, 1 million SNPs. Nature 2007;449:851-861.
19. International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret GB, Munroe PB, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011;478:103-109.
20. Scarborough P, Peto V, Bhatnagar P, et al. Stroke Statistics Oxford. England: British Heart Foundation & Stroke Association; 2009.
21. Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005;366:1773-1783.
22. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-573.
23. Bevan S, Traylor M, Adib-Samii P, et al. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke 2012;43:3161-3167.
24. Le H, Tfelt-Hansen P, Skytthe A, Kyvik KO, Olesen J. Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal populationbased study. BMJ Open 2012;2.
25. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic factor in migraine with aura: a populationbased Danish twin study. Ann Neurol 1999;45:242-246.
26. Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB. The relative role of genetic and environmental factors in migraine without aura. Neurology 1999;53:995-999.
27. Stam AH, Weller CM, Janssens AC, et al. Migraine is not associated with enhanced atherosclerosis. Cephalalgia 2013;33:228-235.
28. van der Harst P, Zhang W, Mateo Leach I, et al. Seventyfive genetic loci influencing the human red blood cell. Nature 2012;492:369-375.
29. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-713.
30. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013; 45:25-33.
31. Johnson AD, Yanek LR, Chen MH, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010;42: 608-613.
32. Tsukada T, Pappas CT, Moroz N, Antin PB, Kostyukova AS, Gregorio CC. Leiomodin-2 is an antagonist of tropomodulin-1 at the pointed end of the thin filaments in cardiac muscle. J Cell Sci 2010;123: 3136-3145.
33. Rajput C, Kini V, Smith M, et al. Neural Wiskott-Aldrich syndrome protein (N-WASP)-mediated p120-catenin interaction with Arp2-Actin complex stabilizes endothelial adherens junctions. J Biol Chem 2013;288:4241-4250.
34. Wegner AM, Nebhan CA, Hu L, et al. N-wasp and the arp2/3 complex are critical regulators of actin in the development of dendritic spines and synapses. J Biol Chem 2008;283:15912-15920.
35. Cooper A, Wraith JE, Savage WJ, Thornley M, Noronha MJ. Beta-mannosidase deficiency in a female infant with epileptic encephalopathy. J Inherit Metabol Dis 1991;14:18-22.
36. Sabourdy F, Labauge P, Stensland HM, et al. A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant. BMC Med Genet 2009;10:84.
37. Xiang M, Feng M, Muend S, Rao R. A human Na1/H1 antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension. Proc Natl Acad Sci USA 2007;104:18677-18681.
38. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet 2013;9:e1003348.